| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Business Development
1 company
Grant Angus serves as an EVP, Business Development at TEVA. Across recent SEC filings that breaks down to 0 buys and 1 sell.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 9, 2024 | TEVA Teva Pharmaceutical Industries Ltd | EVP, Business Development | Sale+OE | 4,065 | $17.28 | $70,243.20 | -31.5% | +0.4% | -6.1% |